Abstract:George-Cosmin Popovici, 1, 2, &ast Costinela-Valerica Georgescu, 3, 4, &ast Claudiu-Ionut Vasile, 5, 6, &ast Oana-Mariana Mihailov, 2, 5, &ast Mihaela-Camelia Vasile, 5, 7, &ast Manuela Arbune 5, 8, &ast 1 School for Doctoral Studies in Biomedical Sciences, "Dunarea de Jos" University, Galati, Romania; 2 Pneumology Department II, Pneumophtisiology Hospital, Galati, Romania; 3 Pharmaceutical Sciences Department, "Dunarea de Jos" University, Galati, Romania; 4 Public Health & Management Department, Gynecology and Obstetrics Clinic Hospital "Buna Vestire", Galati, Romania; 5 Medical Clinic Department, "Dunarea de Jos" University, Galati, Romania; 6 Psychiatry Clinic Department I, "Elisabeta Doamna" Psychiatric Hospital, Galati, Romania; 7 Infectious Diseases Clinic Department II, Clinic Hospital for Infectious Diseases, Galati, Romania; 8 Infectious Diseases Clinic Department I, Clinic Hospital for Infectious Diseases, Galati, Romania &astThese authors contributed equally to this work Correspondence: Costinela-Valerica Georgescu; Claudiu-Ionut Vasile, Email ; Introduction: The COVID-19 pandemic and tuberculosis have epidemiological similarities, being transmitted airborne, favored by direct contact, crowded environments, and vulnerable biological status. Methods: We performed a retrospective study of 45 cases of pulmonary tuberculosis associated with COVID-19 (TB+COV+) compared to 45 cases with tuberculous monoinfection (TB+COV-), hospitalized during 2021– 2022. Results: The demographic characteristics were similar in the two groups, predominating men, a median age of 51 years, living in rural areas, medium level of education and smoking. Common symptoms of the two groups were cough, weight loss, profuse sweating, loss of appetite and hemoptysis, while fever, headache, myo-arthralgias, and digestive symptoms characterized the TB+COV+ forms. The scores of radiological lesions in the TB+COV+ compared to TB+COV- group were significantly higher and persistent, revealing more frequent bilateral extensive lung lesions. There were no significant differences in the biological parameters between the two groups. Mortality was 2.2%, regardless of the association of COVID-19. The frequency of infections with Clostridioides difficile was higher in TB+COV+ cases. Conclusion: The co-infection of COVID-19 had a mild impact on the clinical and biological expression of tuberculosis diagnosed in a pandemic context. Keywords: tuberculosis, COVID-19 pandemic, co-infection, Romania Tuberculosis was one of the leading causes of death in human history and remains one of the leading infectious causes of death in the world. 1 Globally, the number of new cases of tuberculosis exceeds 10 million, although the incidence of tuberculosis has fallen slowly over the past decade, and mortality has fallen by almost a third. 1 Although there has been a downward trend in the incidence of tuberculosis, the achievements are below the indicators established by the World Health Organization [WHO]. The aim of the "END TB" strategy, is to reduce the global TB incidence and mortality rates by 90% and 95%, respectively, in 2035 when compared to 2015. The COVID-19 pandemic has interfered with the diagnosis and care program for tuberculosis, negatively impacting the progress achieved in combating the disease by 2019. The reported number of people diagnosed with TB in 2020 and 2021 has decreased suggesting growing the number of undiagnosed and untreated people, with an estimated 10.6 million reported TB cases in 2021, compared to 10.1 million in 2020. Over more, the number of deaths increased to 1.6 million in 2021 compared to 1.5 million in 2020. 1 COVID-19 has epidemiological similarities with tuberculosis, both infections being airborne, favored by direct contact, crowded environments, and vulnerable biological status. Both tuberculosis and the COVID-19 infection predominantly affect the lung, although extrapulmonary manifestations are also known. The incubation period differs, with variations between 2 and 14 days for COVID-19 and 3–9 weeks for tuberculosis, although they may start with common manifestations, such as cough, chest pain, and asthenia. 2 Tuberculosis is an airborne bacterial infection caused by Mycobacterium tuberculosis that can cause extensive destruction of lung tissue, with the formation of cavities, while COVID-19 is a viral infection primarily transmitted person-to-person, caused by SARS-Cov-2 that alter -Abstract Truncated-

The Impact of Influenza and Tuberculosis Interaction on Mortality Among Individuals Aged ≥15 Years Hospitalized With Severe Respiratory Illness in South Africa, 2010–2016

Impact of Coinfection with SARS-CoV-2 and Influenza on Disease Severity: A Systematic Review and Meta-Analysis

Independent Effect of Weather, Air Pollutants, and Seasonal Influenza on Risk of Tuberculosis Hospitalization: an Analysis of 22-Year Hospital Admission Data.

Changes in the incidence, clinical features and outcomes of tuberculosis during COVID-19 pandemic

Global prevalence, treatment and outcome of tuberculosis and COVID-19 coinfection: a systematic review and meta-analysis (from November 2019 to March 2021)

Systematic review and meta-analysis of Tuberculosis and COVID-19 Co-infection: Prevalence, fatality, and treatment considerations

The impact of pulmonary tuberculosis on SARS-CoV-2 infection: a nationwide cohort study

The Impact of COVID-19 on the Tuberculosis Features in a Romanian Pneumology Hospital

Influenza co-infection associated with severity and mortality in COVID-19 patients

Insufficient tuberculosis treatment leads to earlier and higher mortality in individuals co-infected with HIV in southern China: a cohort study

Impact of Tuberculosis on Disease Severity and Viral Shedding Duration in COVID-19 Patients

Age Differences in Comorbidities, Presenting Symptoms, and Outcomes of Influenza Illness Requiring Hospitalization: A Worldwide Perspective From the Global Influenza Hospital Surveillance Network

Epidemiology of Severe Acute Respiratory Illness and Risk Factors for Influenza Infection and Clinical Severity among Adults in Malawi, 2011-2013

Influenza and bacterial pathogen coinfections in the 20th century.

In- and Out-of-hospital Mortality Associated with Seasonal and Pandemic Influenza and Respiratory Syncytial Virus in South Africa, 2009–2013

Change in patterns of hospitalization for influenza during COVID-19 surges

Colliding Challenges: An Analysis of SARS-CoV-2 Infection in Patients with Pulmonary Tuberculosis versus SARS-CoV-2 Infection Alone

Two Difficult Pandemics: Tuberculosis and COVID-19

Detection of bacterial co-infection in patients with severe influenza

Factors related to in-hospital deaths in patients co-infected with human immunodeficiency virus and tuberculosis